-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bv5XbLGwg0m89w1vS34u8uT9Ycca7tCWzkCNrbmt2rxMcr6Amb6PiQEthliTaHyl sk4mMRTxDgi4LuHzcr8ivA== 0000891618-97-001597.txt : 19970403 0000891618-97-001597.hdr.sgml : 19970403 ACCESSION NUMBER: 0000891618-97-001597 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970402 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MILLENNIUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001002637 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043177038 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-49167 FILM NUMBER: 97573808 BUSINESS ADDRESS: STREET 1: 640 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6176797000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MAYFIELD VII CENTRAL INDEX KEY: 0000895003 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 943167809 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 2800 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 4158545560 MAIL ADDRESS: STREET 1: C/O MAYFIELD FUND STREET 2: 2800 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 SC 13G/A 1 SCHEDULE 13G/A 1 - ------------------------------------ OMB APPROVAL - ------------------------------------ OMB Number: 3235-0145 Expires: December 31, 1997 Estimated average burden hours per response.............14.90 - ------------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* Millennium Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (NAME OF ISSUER) Common Stock - -------------------------------------------------------------------------------- (TITLE OF CLASS OF SECURITIES) 59990210 - -------------------------------------------------------------------------------- (CUSIP NUMBER) * The remainder of this cover page shall be filled out for a reporting person's initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SEC 1745 (2-95) 2 EXPLANATORY NOTES: NOTE 1: The following is a list of all reporting persons [and their respective partners] as originally set forth on a Schedule 13G filed with the Securities and Exchange Commission by Mayfield VII et al., on February 14, 1997, with respect to the ownership of securities of Millennium Pharmaceuticals, Inc.: Mayfield VII Kevin A. Fong Mayfield VII Management Partners William D. Unger Mayfield Medical Partners 1992 Wendell G. Van Auken, III Mayfield Associates Fund II Michael J. Levinthal Yogen K. Dalal A. Grant Heidrich, III F. Gibson Myers, Jr. NOTE 2: This Amendment No. 1 is being filed for the sole purpose of correcting an inadvertent omission of a general partner of Mayfield VII Management Partners in Exhibit C. 3 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. March 31, 1997 ------------------------ Date MAYFIELD VII, A California Limited Partnership By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Authorized Signatory MAYFIELD VII MANAGEMENT PARTNERS A California Limited Partnership By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Authorized Signatory MAYFIELD ASSOCIATES FUND II, A California Limited Partnership By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Authorized Signatory MAYFIELD MEDICAL PARTNERS 1992, A California partnership By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Authorized Signatory YOGEN K. DALAL By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Attorney In Fact 4 F. GIBSON MYERS, JR. By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Attorney In Fact KEVIN A. FONG By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Attorney In Fact WILLIAM D. UNGER By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Attorney In Fact WENDELL G. VAN AUKEN, III By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Attorney In Fact MICHAEL J. LEVINTHAL By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Attorney In Fact A. GRANT HEIDRICH, III By: /s/ George A. Pavlov -------------------------------- George A. Pavlov, Attorney In Fact 5 EXHIBIT C LIST OF GENERAL PARTNERS The following list sets forth the General Partners with respect to certain of the Mayfield Entities: The General Partner of Mayfield VI Investment Partners is Mayfield VI Management Partners. The General Partners of Mayfield VI Management Partners are: (1) F. Gibson Myers, Jr. (4) William D. Unger (2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III (3) Michael J. Levinthal (6) Kevin A. Fong The General Partner of Mayfield VII is Mayfield VII Management Partners. The General Partners of Mayfield VII Management Partners are: (1) F. Gibson Myers, Jr. (4) William D. Unger (2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III (3) Michael J. Levinthal (6) Kevin A. Fong (7) Yogen K. Dalal The General Partners of Mayfield Associates Fund are: (1) F. Gibson Myers, Jr. (4) William D. Unger (2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III (3) Michael J. Levinthal The General Partners of Mayfield Associates Fund II are: (1) F. Gibson Myers, Jr. (4) William D. Unger (2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III (3) Michael J. Levinthal (6) Kevin A. Fong (7) Yogen K. Dalal The General Partner of Mayfield Medical Partners is: (1) Mayfield VI Investment Partners (The General Partners of which have been listed above) The General Partner of Mayfield Medical Partners 1992 is: (1) Mayfield VII (The General Partners of which have been listed above) The General Partners of Mayfield Software Technology Partners are: (1) Mayfield VI Investment Partners (The General Partners of which have been listed above) (2) Yogen K. Dalal -----END PRIVACY-ENHANCED MESSAGE-----